{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:11:13Z","timestamp":1767906673014,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/igc.0000000000000579","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T06:42:48Z","timestamp":1446100968000},"page":"52-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy"],"prefix":"10.1016","volume":"26","author":[{"given":"Ignacio","family":"Zapardiel","sequence":"first","affiliation":[]},{"given":"Mikel","family":"Gorostidi","sequence":"additional","affiliation":[]},{"given":"Antonella","family":"Ravaggi","sequence":"additional","affiliation":[]},{"given":"Maria T.","family":"Allende","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Silveira","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Abehsera","sequence":"additional","affiliation":[]},{"given":"Ronalds","family":"Macuks","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1097\/IGC.0000000000000579_bb0005","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod."},{"key":"10.1097\/IGC.0000000000000579_bb0010","first-page":"375","article-title":"Serum CA-125 in preoperative patients at high risk for endometriosis","volume":"99","author":"Cheng","year":"2002","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000579_bb0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0015-0282(98)00355-0","article-title":"The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis","volume":"70","author":"Mol","year":"1998","journal-title":"Fertil Steril."},{"key":"10.1097\/IGC.0000000000000579_bb0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-121-2-199407150-00009","article-title":"Screening for ovarian cancer","volume":"121","author":"Carlson","year":"1994","journal-title":"Ann Intern Med."},{"key":"10.1097\/IGC.0000000000000579_bb0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0000000000000579_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass","volume":"23","author":"Montagnana","year":"2009","journal-title":"J Clin Lab Anal."},{"key":"10.1097\/IGC.0000000000000579_bb0035","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.fertnstert.2009.10.038","article-title":"Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis","volume":"94","author":"Bordin","year":"2010","journal-title":"Fertil Steril."},{"key":"10.1097\/IGC.0000000000000579_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","article-title":"HE4 in ovarian cancer: from discovery to clinical application","volume":"55","author":"Montagnana","year":"2011","journal-title":"Adv Clin Chem."},{"key":"10.1097\/IGC.0000000000000579_bb0045","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol."},{"issue":"228","key":"10.1097\/IGC.0000000000000579_bb0050","first-page":"e1","article-title":"Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass","volume":"203","author":"Moore","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000579_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol."},{"issue":"349","key":"10.1097\/IGC.0000000000000579_bb0060","first-page":"e1","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000579_bb0065","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000579_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1155\/2013\/984641","article-title":"Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?","volume":"35","author":"Anastasi","year":"2013","journal-title":"Dis Markers."},{"key":"10.1097\/IGC.0000000000000579_bb0075","first-page":"438","article-title":"Is HE4 a useful endometrioma marker?","volume":"35","author":"Leggieri","year":"2014","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1097\/IGC.0000000000000579_bb0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000579_bb0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2012.11.022","article-title":"Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay","volume":"128","author":"Bristow","year":"2013","journal-title":"Gynecol Oncol."},{"issue":"78","key":"10.1097\/IGC.0000000000000579_bb0090","first-page":"e1","article-title":"Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer","volume":"210","author":"Longoria","year":"2014","journal-title":"Am J Obstet Gynecol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2406119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2406119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0000000000000579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:14:26Z","timestamp":1753233266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2406119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1048891X2406119X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0000000000000579","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0000000000000579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2015 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}